Product focus
Lash Growth & Thickness
THECARE / PRODUCT PROTOCOL
Topical useYour guide to preparation, dosing & use.
PRODUCT INFORMATION
Lash Growth & Thickness
Bimatoprost 0.03% (prostaglandin analog)
Clients focused on growing and thickening lashes.
WHAT TO WATCH FOR
Common side effects from Latisse may include mild eye redness, itching, irritation, dryness, watery eyes, eyelid darkening, or longer and thicker lashes. Some people may also notice sensitivity around the eyes or unwanted hair growth if the serum touches surrounding skin.
Stop using the serum and seek medical evaluation if severe irritation develops, vision becomes blurry, swelling occurs, eye infections appear, or if there are unexpected changes in eye color or the surrounding skin.
WHEN TO GET HELP
Red flag symptoms include significant eye pain, swelling, severe redness, vision changes, light sensitivity, discharge, worsening irritation, or signs of an allergic reaction such as rash or difficulty breathing. These symptoms should not be ignored.
Latisse lash serum should not be used, or should only be used with medical clearance, by individuals who are allergic to bimatoprost or any of its ingredients, have active eye inflammation or infections, glaucoma, elevated eye pressure, or who already use prescription prostaglandin eye drops such as Lumigan, latanoprost, or travoprost. Those with a history of retinal swelling, certain cataract surgeries, chronic dry eye, recurrent eye infections, or recent eye procedures should also use caution and consult an eye specialist beforehand. Pregnant or breastfeeding individuals are generally advised to avoid it due to limited safety data. Additionally, people concerned about orbital fat loss or a more hollow or sunken appearance around the eyes may want to avoid prostaglandin-based lash serums like Latisse, as they have been associated with periorbital fat atrophy in some users. Common side effects may include redness, itching, irritation, eyelid darkening, dry eyes, and unwanted hair growth if the serum spreads onto surrounding skin, while rare cases of permanent iris darkening have also been reported.
Medical conditions and medications that should be reviewed before use include glaucoma, elevated eye pressure, dry eye syndrome, eye infections, recent eye surgery, retinal conditions, or use of prescription eye drops such as prostaglandin medications like Lumigan, latanoprost, or travoprost. Pregnancy and breastfeeding should also be discussed with a medical provider before starting treatment.
MEASURE CORRECTLY
YOUR DOSE · FOLLOW YOUR PRESCRIPTION
Apply once daily at night to the skin of the upper eyelid margin at the base of the eyelashes.
140 single-use applicators = 70 two-eye nightly applications when using one new applicator per eye.
Once you reach your desired lash length and fullness, reduce application to 2–3 times weekly only if your prescriber instructs you to do so.
This product is applied with sterile applicators; syringe units are not used.
| Eye | Applicator | Solution |
|---|---|---|
| First eye | 1 new sterile applicator | 1 drop on applicator |
| Other eye | 1 different new applicator | 1 drop on applicator |
Do not calculate a dose from the 5 mL bottle size or reuse an applicator.
The Latisse 5mL kit contains one 5mL bottle of prescription-strength bimatoprost ophthalmic solution (0.03%) and a supply of 140 sterile, disposable applicators
Store at 2–25°C. Keep the bottle closed and follow its expiry date.
USE & FOLLOW-UP
Clean the face and remove makeup and contact lenses. Wash and dry hands.
Put one drop near the tip of a new sterile applicator. Draw it across the skin of the upper eyelid margin at the base of the lashes. Blot excess.
Repeat on the other upper eyelid with a different new applicator. Do not apply to the lower lid or reuse applicators.
Discard applicators, close the bottle without touching its tip, and replace contact lenses after at least 15 minutes if needed.
Do not double, repeat, or titrate without the written order. Contact the clinic for a discrepancy, uncertain storage, or unexpected reaction; urgent symptoms need emergency care.
Reorder based on remaining applicators/solution and the bottle expiry, not an assumed four-month supply.